Selected article for: "clinical practice and feasibility study"
Author: van de Hei, Susanne; McKinstry, Steven; Bardsley, George; Weatherall, Mark; Beasley, Richard; Fingleton, James
Title: Randomised controlled trial of rhinothermy for treatment of the common cold: a feasibility study
  • Document date: 2018_3_27
    • ID: iys2ezkd_85
    Snippet: The difference between the randomised groups was observed within 24 hours, so that the 432 efficacy of single dose regimens or sessions over a two to three day period, which may enhance 433 its implementation in clinical practice, will be worth further study. However, while alternative 434 rhinothermy regimens will need to be assessed, our study findings suggest that the regimen 435 used in this feasibility study should also be used in future RCT.....
    Document: The difference between the randomised groups was observed within 24 hours, so that the 432 efficacy of single dose regimens or sessions over a two to three day period, which may enhance 433 its implementation in clinical practice, will be worth further study. However, while alternative 434 rhinothermy regimens will need to be assessed, our study findings suggest that the regimen 435 used in this feasibility study should also be used in future RCTs. 436

    Search related documents:
    Co phrase search for related documents
    • assess need and day period: 1
    • assess need and feasibility study: 1, 2, 3, 4, 5, 6
    • assess need and single dose: 1
    • clinical practice and day period: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • clinical practice and feasibility study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • clinical practice and randomised group: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • clinical practice and single dose: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • clinical practice and study finding: 1, 2, 3, 4
    • day period and feasibility study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • day period and randomised group: 1
    • day period and single dose: 1, 2, 3, 4, 5, 6, 7, 8
    • day period and study finding: 1, 2, 3, 4
    • feasibility study and future rct: 1, 2, 3, 4
    • feasibility study and randomised group: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • feasibility study and single dose: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • feasibility study and study finding: 1, 2, 3, 4, 5
    • future rct and randomised group: 1, 2
    • randomised group and single dose: 1, 2, 3, 4, 5, 6, 7, 8